Metallocene
Metallocene refers to a class of compounds typically consisting of two cyclopentadienyl anions (Cp, which is a five-carbon ring) bound to a metal center (M) in the oxidation state II, forming a sandwich-like structure. These compounds are a subset of a larger class of compounds known as organometallics. The general formula for metallocenes is (Cp)_2M. The most well-known example is ferrocene, with the iron (Fe) metal center, which was the first of its kind to be discovered in 1951. This discovery sparked significant interest in the study of organometallic chemistry, leading to the development of a wide variety of metallocene compounds with different metal centers, including titanium (Ti), zirconium (Zr), and others.
Metallocenes have been extensively studied for their unique chemical properties, including their ability to undergo redox reactions, serve as catalysts in polymerization reactions, and their potential applications in medicine, materials science, and nanotechnology. In the field of polymer chemistry, metallocene catalysts are used to produce polyolefins with specific molecular weights and structures, leading to materials with desirable properties such as improved strength, flexibility, and chemical resistance.
The structure of metallocenes involves the metal center being sandwiched between two parallel cyclopentadienyl rings. This arrangement allows for a high degree of symmetry and contributes to the stability of the compound. The bonding between the metal and the cyclopentadienyl rings involves the donation of electrons from the filled π orbitals of the cyclopentadienyl anions to the empty d orbitals of the metal, creating a strong metal-to-ligand bond.
Research in the area of metallocenes continues to be a vibrant field, with scientists exploring their potential in various applications, including as catalysts for environmentally friendly chemical processes, in the development of new materials with advanced functionalities, and in the design of novel therapeutic agents.
Metallocene gallery
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD